2012 - As stated by the World Health Organization (WHO) healthcare has become one of the most pressing concerns in the 21st century as the people continue to live longer lives and the world's population continues to increase. It is in this situation that the PBRX group finds itself in the midst of with its first IPO release. Known within the healthcare industry as a "life extension company" the PBRX group works with its group of German scientists to develop product which help to sustain health and improve the condition of the aged. It is in this regard that the PBRX group has recently announced its intent for a possible IPO by the middle or end of 2012 so as to ramp up operations by 2013. It is expected that should a significant degree of public interest be generated in the company's first release of stock the resulting capital will be able to result in a far faster product release. As such for investors looking to capitalize and invest into an up and coming company in the pharmaceutical industry PBRX seems to be the ideal place to start. While the company has just recently been newly incorporated it has already generated quite a bit of "buzz" within the investment community. Various investment analysts such as Tom Jones have speculated that with the current investment environment the way it is at the present with a large number of investors focusing on tech companies such as Apple, Facebook, Zynga, LinkedIn etc. the "hidden" IPO release of the PBRX group should prove to be a rather lucrative investment to the cadre of investors looking to sink their teeth so to speak into an up and coming company in the pharmaceutical industry. As of late there has been a significant degree of investor interest in the PBRX research group with its potential IPO release in the latter half of 2012. While being relatively small in size compared to some of the larger pharmaceutical and healthcare companies the PBRX group makes up for this in the quality of its research team which is composed of a variety of researchers from Germany. With its capital it already accumulated from venture capitalists the company has been working hard in developing its first product line and as such in order to begin ramping up operations it plans to have its first IPO in order to generate sufficient capital for a great product release. It must be noted though that several investors are being hesitant in investing with the company due to its relative "youth" however analysts such as Tom Jones have stated that after looking over the company's finances and products it currently has in development investing into the PBRX group seems to be a good choice for people looking towards investing into a growing industry.